Biotech · Private company
Metro International Biotech, LLC
Track this companyFree. Adds Metro International Biotech, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials52 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- Home TreatmentPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Investigational Product - MIB 626Phase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MIB-626Phase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- MIB-626Phase 2 · Friedreich AtaxiaClinicalTrials.gov · fetched Nov 12, 2026
- Standardized, progressive, high intensity, multidimensional exercisePhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Usual Physical ActivityPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- MIB-725Phase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
- Nicotinamide (NAM)Phase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
- Nicotinamide Mononucleotide (NMN)Phase 1 · Healthy AdultsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Tracing the Metabolic Flux of Orally Administered NAD+ PrecursorsPHASE1 · RECRUITING · started Apr 28, 2025ClinicalTrials.gov NCT06882096 · fetched Nov 12, 2026
- Phase 1a Single Ascending Dose Study of MIB-725 in Healthy AdultsPHASE1 · RECRUITING · started Feb 11, 2025ClinicalTrials.gov NCT06815991 · fetched Nov 12, 2026
- Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training ProgramPHASE2 · COMPLETED · started Oct 25, 2023ClinicalTrials.gov NCT05878119 · fetched Nov 12, 2026
- Phase 2a MIB-626 vs. Placebo COVID-19PHASE2 · COMPLETED · started Oct 26, 2021ClinicalTrials.gov NCT05038488 · fetched Nov 12, 2026
- NAD+ Precursor Supplementation in Friedreich's AtaxiaPHASE2 · COMPLETED · started May 17, 2021ClinicalTrials.gov NCT04817111 · fetched Nov 12, 2026